Rheumatoid arthritis

Plasma Matrix Metalloproteinase Concentrations and Risk of Interstitial Lung Disease in a Prospective Rheumatoid Arthritis Cohort

Arthritis RheumatolPublished Prospective cohort study with cross-sectional analysis

Main finding · Prevalent ILD (MMP-7, highest quartile)Result — go to the resultAdjusted odds ratio 3.78 95% CI 1.86–7.65

Authors' conclusion

MMP-7 and MMP-9 were strongly associated with both prevalent and incident ILD in this large, multicenter RA cohort after adjustment for other RA-ILD risk factors.

Study context

Population
US veterans with rheumatoid arthritis (RA) in a multicentre prospective cohort (88.9% male; mean age 63.8 years)
Participants
2,312 veterans17,378 person-years
Exposure
Highest vs lower quartiles of plasma MMP concentrations
Outcome
Prevalent and incident ILD
Methodological detailsmulticentre, logistic and Cox regression adjusted for RA-ILD risk factors, matrix metalloproteinases (MMPs) categorized into quartiles
  • Multicentre
  • Logistic and Cox regression adjusted for RA-ILD risk factors
  • MMPs categorized into quartiles

Main finding

Prevalent ILD (MMP-7, highest quartile)

Adjusted odds ratio

3.78

95% CI 1.86–7.65

Highestvs lower quartiles of plasma MMP concentrations
aOR 3.78 (95% CI 1.86–7.65)

As reported in the abstract

Prevalent interstitial lung disease (ILD)
96

Observational data: associations, not effects.

Further findings

Incident ILD (MMP-7, highest quartile)

aHR (95% CI)
Highest MMP-7 quartile2.33 (1.35–4.02)
Incident ILD (MMP-7, highest quartile) — Incident ILD cases
130
Incident ILD (MMP-7, highest quartile) — Crude incidence rate (/1,000 person-years)
7.5

MMP-9 and ILD

MMP-9 correlation with FVC in prevalent ILD (r)
−0.30, P = 0.005
Higher MMP-9 associated with prevalent and incident ILD

Original publication

Plasma Matrix Metalloproteinase Concentrations and Risk of Interstitial Lung Disease in a Prospective Rheumatoid Arthritis Cohort. Arthritis Rheumatol. Published 15 February 2024. doi:10.1002/art.42812

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.